Delpor, Inc.

Delpor, Inc.

生物技术

Brisbane,CA 2,846 位关注者

Once-Yearly Therapies for Chronic Conditions

关于我们

Delpor is a clinical stage life sciences company that utilizes innovative drug-delivery technologies in order to develop once-yearly therapies for chronic conditions. The Company’s lead product is a 6-12-month formulation of Risperidone (drug/device combination product) for the treatment of schizophrenia. Delpor is also pursuing 6-12 month formulations of other drugs targeting CNS conditions including Neuromuscular Diseases, Neurodegenerative Diseases, Addiction, and other disorders.

网站
http://delpor.com
所属行业
生物技术
规模
11-50 人
总部
Brisbane,CA
类型
私人持股
创立
2009
领域
Drug Delivery、Biotech、Scizophrenia、Diabetes、Mental Illnesses、Research and Development、Nanotechnology、Peptides、Proteins和Small Molecules

地点

  • 主要

    150 North Hill Drive

    Suite 25

    US,CA,Brisbane,94005

    获取路线

Delpor, Inc.员工

动态

相似主页

查看职位

融资